Industry Symposium 2021

Saturday, March 27th, 2021, 10:00 – 10:15am (ET)
Contrast Enhanced Spectral Mammography (CESM) Guided Biopsy – Initial Clinical Experience

Speaker: Dr. Anat Kornecki, MD, FRCPC

Session objectives:

  • To introduce the CESM guided biopsy devise
  • To provide examples of different clinical settings of its use
  • To share the initial results of tour centre trial

Biography: Dr. Anat Kornecki

Associate Professor for the Department of Medical Imaging
St. Joseph’s Health Care
London, Ontario, Canada

Dr. Anat Kornecki is an Associate Professor at the department of Medical Imaging at St. Joseph’s Health Care in London, Canada.

She graduated medical school and radiology residency program in Tel-Aviv University and completed Abdominal Imaging and Women Imaging fellowships at the University of Toronto.

She is an Associate professor and head of the Division of Breast Imaging at Western University, Canada and Scientist Associate at Lawson and Robarts institutes, focusing on breast imaging.

Dr. Anat Kornecki has organized and presented at many national and international educational events.

Saturday, March 27th, 2021, 12:30 – 12:50pm (ET)
Practical Solutions for Implementation of Contrast Enhanced Mammography

Speaker: Dr. Ryan Gabriel

This webinar will discuss the basics of Contrast Enhanced Mammography (CEM) and provide practical solutions for introducing CEM into your practice.

It includes the following objectives:

  • Identifying key equipment and staffing components for the implementation of CEDM
  • Workflow solutions for implementing CEDM in your practice
  • Considerations for utilizing CEDM as a new tool for diagnostic imaging

Biography: Dr. Ryan Gabriel

Ryan Gabriel

Dr. Ryan Gabriel, MD is a board certified Diagnostic Radiologist specializing in Breast Imaging. He is employed by Radiology Associates of Richmond and currently serves as the Director of Breast Imaging at Henrico Doctors’ Hospital in Richmond, VA.

Dr. Gabriel obtained his medical degree and completed his residency in Diagnostic Radiology at Virginia Commonwealth University / Medical College of Virginia. He completed a Fellowship in Breast Imaging and Intervention at University of Virginia, Charlottesville, VA.

Saturday, March 27th, 2021, 1:10 – 1:30pm (ET)
The Malmö trial and wide-angle breast tomosynthesis

Speaker: Dr. Sophia Zackrisson

The superiority of digital breast tomosynthesis (DBT) compared to digital mammography (DM) for cancer detection in screening is undoubted, as indicated by the results from several large, prospective screening trials. The Malmö Breast Tomosynthesis Screening Trial involving 15000 women in Malmö, Sweden is unique in the sense that it investigated wide-angle, 1-view DBT with reduced compression and still gave results on par with more extensive imaging protocols in other trials. The trial showed an increase in cancer detection of 34% and acceptable recall rates. Our most recent results show that the rate of interval cancers decreased after screening with DBT compared to a large, contemporary control group screened with digital mammography. This is important information adding to the growing evidence of DBT contributing to even an more effective breast cancer screening.

Biography: Dr. Sophia Zackrisson

Sophia Zackrisson

Prof. Zackrisson is Professor of Radiology at Lund University and senior consultant radiologist at Skåne University Hospital Malmö, Sweden. She has a PhD in epidemiology with a thesis on mammography screening. In 2011 she was visiting scholar at Stanford University, Ca, USA, focusing on molecular imaging and magnetic resonance imaging. One of her largest clinical and epidemiological studies as PI is the Malmö Breast Tomosynthesis Screening Trial. Further research and clinical interests are colorectal and prostate cancer and metastatic disease. Prof. Zackrisson is chair of the Swedish Society of Breast Imaging, chair of the Swedish Translational Research in Breast Cancer and executive board member of European Society of Breast Imaging since 2017. She is author of numerous scientific papers and book chapters. In 2020 she was named “Cancer Researcher of the Year” by the Swedish Cancer Society for her contributions in cancer imaging.